ctrl K

Watchlist Price Alert

Conduit Pharmaceuticals I... (CDT)

NASDAQ: CDT · Real-Time Price · USD

2.45

0.15 (6.52%)

At close: Jun 17, 2025, 10:56 AM

Conduit Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	922.22M	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	922.22M	n/a	n/a	n/a
Operating Income	266.46M	-5.56M	-3.16M	-3.17M
Interest Income	n/a	15K	1.98M	n/a
Pretax Income	-17.8M	-535K	-4.89M	-4.38K
Net Income	198.43M	-535K	-4.89M	-3.66M
Selling & General & Admin	12.04M	5.47M	3.05M	2.89M
Research & Development	3.38M	90K	111K	283K
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	15.42M	5.56M	3.16M	3.17M
Interest Expense	n/a	211K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	15.42M	5.56M	3.16M	3.17M
Income Tax Expense	-29.53M	-168K	374.86K	247.44K
Shares Outstanding (Basic)	40.69M	33.49M	72.42M	11.52K
Shares Outstanding (Diluted)	41.3M	33.95M	72.42M	11.52K
EPS (Basic)	4.88	-0.18	-0.56	-0.05
EPS (Diluted)	4.80	-0.18	-0.56	-0.05
EBITDA	266.46M	-324K	-1.43M	-4.38K
EBIT	189.64M	-324K	-4.89M	-4.38K
Depreciation & Amortization	457K	167.9K	1.73M	n/a